| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Anti-müllerian hormone levels are reduced in women living with human immunodeficiency virus compared to control women: a case–control study from Copenhagen, Denmark
|
Wessman, Maria
|
|
|
4 |
2 |
p. 123-127
|
article
|
| 2 |
Bioequivalent pharmacokinetics for generic and originator hepatitis C direct-acting antivirals
|
Hill, Andrew
|
|
|
4 |
2 |
p. 128-131
|
article
|
| 3 |
Ethical challenges in developing an educational video to empower potential participants during consent processes in HIV cure research in South Africa
|
Staunton, Ciara
|
|
|
4 |
2 |
p. 99-102
|
article
|
| 4 |
Heterogeneity in hepatitis C treatment prescribing and uptake in Australia: a geospatial analysis of a year of unrestricted treatment access
|
Scott, Nick
|
|
|
4 |
2 |
p. 108-114
|
article
|
| 5 |
Highlights from the 8th International Workshop on HIV Persistence during Therapy, 12–15 December 2017, Miami, FL, USA
|
Psomas, Christina K.
|
|
|
4 |
2 |
p. 132-142
|
article
|
| 6 |
Impact of an educational video as a consent tool on knowledge about cure research among patients and caregivers at HIV clinics in South Africa
|
Hendricks, Melany
|
|
|
4 |
2 |
p. 103-107
|
article
|
| 7 |
Implementation of hepatitis C cure in Australia: one year on
|
Richmond, Jacqueline A.
|
|
|
4 |
2 |
p. 115-117
|
article
|
| 8 |
In memoriam David Cooper
|
|
|
|
4 |
2 |
p. i
|
article
|
| 9 |
Intensification of antiretroviral treatment with raltegravir for pregnant women living with HIV at high risk of vertical transmission
|
Puthanakit, Thanyawee
|
|
|
4 |
2 |
p. 61-65
|
article
|
| 10 |
Latent HIV dynamics and implications for sustained viral suppression in the absence of antiretroviral therapy
|
Murray, John M.
|
|
|
4 |
2 |
p. 91-98
|
article
|
| 11 |
Outpatient directly observed therapy for hepatitis C among people who use drugs: a systematic review and meta-analysis
|
McDermott, Cara L.
|
|
|
4 |
2 |
p. 118-122
|
article
|
| 12 |
Safety and pharmacokinetics of dolutegravir in HIV-positive pregnant women: a systematic review
|
Hill, An.drew
|
|
|
4 |
2 |
p. 66-71
|
article
|
| 13 |
Tenofovir alafenamide versus tenofovir disoproxil fumarate: is there a true difference in efficacy and safety?
|
Hill, Andrew
|
|
|
4 |
2 |
p. 72-79
|
article
|
| 14 |
The impact of HIV prevalence, conflict, corruption, and GDP/capita on treatment cascades: data from 137 countries
|
Levi, Jacob
|
|
|
4 |
2 |
p. 80-90
|
article
|
Journal description